A Retrospective Analysis of Clinical Biomarkers for Olaparib Maintenance Therapy in Patients with Recurrent Ovarian Cancer.

Endo, Shun; Shigeta, Shogo; Tokunaga, Hideki; Shimizu, Takanori; Hasegawa-Minato, Junko; Hashimoto, Chiaki; Ishibashi, Masumi; Nagai, Tomoyuki; Shiga, Naomi; Shimada, Muneaki; Yaegashi, Nobuo

Endo, Shun; Shigeta, Shogo; Tokunaga, Hideki; Shimizu, Takanori; Hasegawa-Minato, Junko; Hashimoto, Chiaki; Ishibashi, Masumi; Nagai, Tomoyuki; Shiga, Naomi; Shimada, Muneaki; Yaegashi, Nobuo.

Afiliación

Endo S; Department of Obstetrics and Gynecology, Tohoku University School of Medicine.
Shigeta S; Department of Obstetrics and Gynecology, Tohoku University School of Medicine.
Tokunaga H; Department of Obstetrics and Gynecology, Tohoku University School of Medicine.
Shimizu T; Department of Obstetrics and Gynecology, Tohoku University School of Medicine.
Hasegawa-Minato J; Department of Obstetrics and Gynecology, Tohoku University School of Medicine.
Hashimoto C; Department of Obstetrics and Gynecology, Tohoku University School of Medicine.
Ishibashi M; Department of Obstetrics and Gynecology, Tohoku University School of Medicine.
Nagai T; Department of Obstetrics and Gynecology, Tohoku University School of Medicine.
Shiga N; Department of Obstetrics and Gynecology, Tohoku University School of Medicine.
Shimada M; Department of Obstetrics and Gynecology, Tohoku University School of Medicine.
Yaegashi N; Department of Obstetrics and Gynecology, Tohoku University School of Medicine.

Tohoku J Exp Med ; 258(1): 1-9, 2022 Aug 05.

Article en En | MEDLINE | ID: mdl-35705321

Asunto(s)

Recurrencia Local de Neoplasia; Neoplasias Ováricas; Biomarcadores; Carcinoma Epitelial de Ovario/tratamiento farmacológico; Femenino; Humanos; Recurrencia Local de Neoplasia/tratamiento farmacológico; Neoplasias Ováricas/tratamiento farmacológico; Neoplasias Ováricas/patología; Ftalazinas; Piperazinas; Inhibidores de Poli(ADP-Ribosa) Polimerasas/farmacología; Inhibidores de Poli(ADP-Ribosa) Polimerasas/uso terapéutico; Estudios Retrospectivos

Palabras clave

PARP inhibitor; homologous recombination deficiency; olaparib; progression free survival; recurrent ovarian cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Recurrencia Local de Neoplasia Tipo de estudio: Observational_studies Límite: Female / Humans Idioma: En Revista: Tohoku J Exp Med Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google